5351. Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Issue 11 (18th September 2020) Authors: Azizi, Armon; Ediriwickrema, Asiri; Dutta, Ritika; Patel, Shyam A.; Shomali, William; Medeiros, Bruno; Iberri, David; Gotlib, Jason; Mannis, Gabriel; Greenberg, Peter; Majeti, Ravindra; Zhang, Tian Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5352. Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Issue 11 (18th September 2020) Authors: Azizi, Armon; Ediriwickrema, Asiri; Dutta, Ritika; Patel, Shyam A.; Shomali, William; Medeiros, Bruno; Iberri, David; Gotlib, Jason; Mannis, Gabriel; Greenberg, Peter; Majeti, Ravindra; Zhang, Tian Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5353. Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series. Issue 13 (10th November 2021) Authors: Wan, Chao-Ling; Zou, Jing-Ying; Qiao, Man; Yin, Jia; Shen, Xiang-Dong; Qiu, Qiao-Cheng; Liu, Song-Bai; Xue, Sheng-Li Journal: Leukemia & lymphoma Issue: Volume 62:Issue 13(2021) Page Start: 3300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5354. Venetoclax in acute myeloid leukemia – current and future directions. Issue 6 (11th May 2020) Authors: Lachowiez, Curtis; DiNardo, Courtney D.; Konopleva, Marina Journal: Leukemia & lymphoma Issue: Volume 61:Issue 6(2020) Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5355. Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease. Issue 4 (21st March 2023) Authors: Sanber, Khaled; Ye, Kevin; Tsai, Hua-Ling; Newman, Matthew; Webster, Jonathan A.; Gojo, Ivana; Ghiaur, Gabriel; Prince, Gabrielle T.; Gondek, Lukasz P.; Smith, B. Douglas; Levis, Mark J.; DeZern, Amy E.; Ambinder, Alexander J.; Dalton, William B.; Jain, Tania Journal: Leukemia & lymphoma Issue: Volume 64:Issue 4(2023) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5356. Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia. Issue 7 (7th June 2022) Authors: Graveno, Molly E.; Carulli, Alison; Freyer, Craig W.; Mangan, Brendan L.; Nietupski, Robert; Loren, Alison W.; Frey, Noelle V.; Porter, David L.; Gill, Saar I.; Hexner, Elizabeth O.; Luger, Selina M.; Martin, Mary Ellen; McCurdy, Shannon R.; Perl, Alexander E.; Babushok, Daria V.; Pratz, Keith W. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 7(2022) Page Start: 1645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5357. Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression. Issue 3 (23rd February 2022) Authors: Roy, Tina; An, Joseph B.; Doucette, Kimberly; Chappell, Aimee M.; Vesole, David H. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 3(2022) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5358. Venetoclax induced complete remission in extramedullary relapse of AML co-harboring NPM1, TET2, and NRAS mutations after haploidentical hematopoietic stem cell transplantation. Issue 11 (18th September 2020) Authors: Pan, Wenjue; Zhao, Xiujie; Shi, Wei; Jiang, Zhinong; Xiao, Haowen Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5359. Venetoclax is safe and efficacious in relapsed/refractory AML. Issue 9 (28th July 2020) Authors: Ganzel, Chezi; Ram, Ron; Gural, Alexander; Wolach, Ofir; Gino-Moor, Sharon; Vainstein, Vladimir; Nachmias, Boaz; Apel, Arie; Koren-Michowitz, Maya; Pasvolsky, Oren; Yerushalmi, Ronit; Danylesko, Ivetta; Cohen, Yosef; Peretz, Galit; Moshe, Yakir; Zektser, Miri; Yeganeh, Shay; Rowe, Jacob M.; Ofran... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 9(2020) Page Start: 2221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5360. Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia. Issue 9 (29th July 2021) Authors: Arora, Sankalp; Vachhani, Pankit; Bachiashvili, Kimo; Jamy, Omer Journal: Leukemia & lymphoma Issue: Volume 62:Issue 9(2021) Page Start: 2292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗